EcoDrugPlus

Mast/stem Cell Growth Factor Receptor Kita-Like

Ensembl ID : ENSCGOG00000017978
Gene Symbol: LOC115014745
3 Cross references
207 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSCGOG00000024152
Gene Symbol: MMP1
3 Cross references
308 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSCGOG00000004062
Gene Symbol: MMP1
1 Cross references
308 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSCGOG00000022573
Gene Symbol: MMP2
3 Cross references
210 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSCGOG00000024463
Gene Symbol: MMP9
3 Cross references
216 Possible Orthologues:

Matrix Metalloproteinase-14-Like

Ensembl ID : ENSCGOG00000011530
Gene Symbol: LOC115023741
3 Cross references
199 Possible Orthologues:

Matrix Metalloproteinase-14-Like

Ensembl ID : ENSCGOG00000005823
Gene Symbol: LOC115022907
3 Cross references
198 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSCGOG00000011183
Gene Symbol: MTOR
3 Cross references
222 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSCGOG00000020267
Gene Symbol: MC1R
3 Cross references
159 Possible Orthologues:

Melanocortin Receptor 4-Like

Ensembl ID : ENSCGOG00000021415
Gene Symbol: LOC115025688
3 Cross references
211 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSCGOG00000018850
Gene Symbol: MTNR1A
3 Cross references
190 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSCGOG00000002184
Gene Symbol: MME
3 Cross references
234 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).